DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR DS-5565

« Back to Dashboard

Clinical Trials for DS-5565

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT01496365	Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy	Completed	Daiichi Sankyo Inc.	Phase 2	The purpose of this study is to evaluate the safety, tolerability and effectiveness of DS-5565 compared to placebo (inactive substance) and pregabalin in diabetic subjects with DPN.
NCT01504412	Asian Phase 2 Study for Treatment of Pain Associated With Diabetic Peripheral Neuorpathy	Completed	Daiichi Sankyo Co., Ltd.	Phase 2	The purpose of this study is to investigate the effectiveness and safety of DS-5565, compared to placebo, in subjects with pain associated with diabetic peripheral neuropathy.
NCT02146430	Treatment of Pain Associated With Fibromyalgia	Active, not recruiting	INC Research	Phase 3	DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02146430	Treatment of Pain Associated With Fibromyalgia	Active, not recruiting	Daiichi Sankyo Inc.	Phase 3	DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02187159	Treatment of Pain Associated With Fibromyalgia	Active, not recruiting	INC Research	Phase 3	DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02187159	Treatment of Pain Associated With Fibromyalgia	Active, not recruiting	Daiichi Sankyo Inc.	Phase 3	DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.
NCT02187471	Treatment of Pain Associated With Fibromyalgia	Active, not recruiting	INC Research	Phase 3	DS 5565 will be better than placebo (sugar pill without active drug) in managing fibromyalgia pain and will be well tolerated.

Clinical Trial Conditions for DS-5565

Condition Name

Condition Name for
Intervention	Trials
Pain Associated With Fibromyalgia	4
Diabetic Peripheral Neuropathic Pain	3
Post-herpetic Neuralgia	2
Diabetic Peripheral Neuropathy	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for
Intervention	Trials
Neuralgia	6
Diabetic Neuropathies	5
Myofascial Pain Syndromes	5
Fibromyalgia	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for DS-5565

Trials by Country

Trials by Country for
Location	Trials
United States	166
United Kingdom	29
Canada	10
Australia	10
France	6

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for
Location	Trials
Florida	6
Arizona	6
Texas	6
Tennessee	6
South Carolina	6

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for DS-5565

Clinical Trial Phase

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 3	10
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for
Clinical Trial Phase	Trials
Active, not recruiting	6
Recruiting	3
Completed	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for DS-5565

Sponsor Name

Sponsor Name for
Sponsor	Trials
Daiichi Sankyo Co., Ltd.	6
Daiichi Sankyo Inc.	6
INC Research	4

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for
Sponsor	Trials
Industry	17
Other	4

Export unavailable in trial.
Subscribe for complete access.